Advertisement

Patient-Reported Outcomes in Penile Cancer Patients: Quality of Life, Sexual and Urinary Function. What do we Know?

  • Kevin A. Diaz
    Affiliations
    UROGIV Research Group, Department of Surgery, School of Medicine. Universidad del Valle, Cali, Colombia
    Search for articles by this author
  • Philippe E. Spiess
    Affiliations
    Department of Genito-Urinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

    Department of GU Oncology and Tumor Biology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

    Urology and Oncology, University of South Florida, Tampa, FL
    Search for articles by this author
  • Herney Andrés García-Perdomo
    Correspondence
    Address correspondence to Herney Andrés García-Perdomo, M.D. M.Sc EdD PhD FACS Universidad del Valle, Cali Cll 4b # 36-00, Colombia.
    Affiliations
    UROGIV Research Group, Department of Surgery, School of Medicine. Universidad del Valle, Cali, Colombia

    Division of Urology/Urooncology, Department of Surgery, School of Medicine, Universidad del Valle, Cali, Colombia
    Search for articles by this author
      Penile cancer is a rare genitourinary malignancy disease responsible for less than 1% of diagnosed cancers in men in the USA, with mortality reported to 300 deaths for a year.
      • Siegel RL
      • Miller KD
      • Jemal A.
      Cancer statistics, 2020.
      However, its incidence varies according to the population studied, with multiple risk factors described and usually diagnosed in men over 50 years. Historically, surgery has been the cornerstone of the treatment of the disease, achieving satisfactory oncological outcomes but with a high cost at generating a disastrous impact on the quality of life and the male mind for the post-treatment sequels.

      Ahmed ME, Khalil MI, Kamel MH, Karnes RJ, Spiess PE. Progress on management of penile cancer in 2020. Curr Treat Options Oncol. 2020;22:4. https://doi.org/10.1007/s11864-020-00802-3.

      Nevertheless, in the last few years, penile cancer management has changed its diagnostics and therapeutics approaches with the intention to avoid radical surgeries. Currently, the penile-preserving procedures have shown comparable outcomes in selected patients and allow maintaining their cosmetic and sexual function.
      • Youssef I
      • Hoogland AI
      • Chahoud J
      • Spiess PE
      • Jim H
      • Johnstone PAS
      Patient reported outcomes in advanced penile cancer.
      Although, there are only few reports over the role of patient-reported outcome measures (PROMs), these studies stand out vital elements for patient-centered decision-making.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Siegel RL
        • Miller KD
        • Jemal A.
        Cancer statistics, 2020.
        CA Cancer J Clin. 2020; 70: 7-30
      1. Ahmed ME, Khalil MI, Kamel MH, Karnes RJ, Spiess PE. Progress on management of penile cancer in 2020. Curr Treat Options Oncol. 2020;22:4. https://doi.org/10.1007/s11864-020-00802-3.

        • Youssef I
        • Hoogland AI
        • Chahoud J
        • Spiess PE
        • Jim H
        • Johnstone PAS
        Patient reported outcomes in advanced penile cancer.
        Urol Oncol. 2022; (May; Available from:)
      2. Douglawi A, Masterson TA. Penile cancer epidemiology and risk factors: A contemporary review. Curr Opin Urol. 2019;29:145–149. https://doi.org/10.1097/MOU.0000000000000581.

      3. Tseng HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a population-based case±control study in Los Angeles County (United States).

        • Madsen BS
        • van den Brule AJC
        • Jensen HL
        • Wohlfahrt J
        • Frisch M.
        Risk factors for squamous cell carcinoma of the penis - Population-based case-control study in Denmark.
        Cancer EpidemiolBiomarkers Prev. 2008; 17: 2683-2691
      4. Maden C, Sherman KJ, Beckmann AM, et al. ARTICLES history of circumcision, medical conditions, and sexual activity and risk of penile cancer [Internet]. Available from: http://jnci.oxfordjournals.org/

      5. Morris BJ, Bailis SA, Wiswell TE. Circumcision rates in the united states: Rising or falling? What Effect Might the new Affirmative Pediatric Policy Statement Have?. Mayo Clin Proc. 2014;89(5):677–86. https://doi.org/10.1016/j.mayocp.2014.01.001.

        • Chipollini J
        • Tang DH
        • Sharma P
        • Spiess PE.
        National trends and Predictors of organ-sparing for invasive penile tumors: expanding the therapeutic window.
        Clin Genitourin Cancer. 2018; 16: e383-e389
        • Shabbir M
        • Minhas S
        • Muneer A.
        Diagnosis and management of premalignant penile lesions.
        Therapeutic Adv Urol. 2011; 3: 151-158
        • Maddineni SB
        • Lau MM
        • Sangar VK.
        Identifying the needs of penile cancer sufferers: a systematic review of the quality of life, psychosexual and psychosocial literature in penile cancer.
        BMC Urol. 2009; 9
      6. Hakenberg O, Compérat E, Minhas S, Necchi N, Protzel C, Watkin N, Robinson R. EAU Penile Cancer Guidelines. European Association of Urology 2022. Available in: https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Penile-Cancer-2022.pdf

        • Kidd LC
        • Chaing S
        • Chipollini J
        • Giuliano AR
        • Spiess PE
        • Sharma P.
        Relationship between human papillomavirus and penile cancer-implications for prevention and treatment.
        Transl Androl Urol. 2017; 6: 791-802
        • Pettaway CA
        • Spiess PE.
        Multimodality treatment of penile cancer: Part 1.
        Urologic Oncology: Seminars and Original Investigations. 40. Elsevier Inc., 2022: 171-172
        • Draeger DL
        • Sievert KD
        • Hakenberg OW.
        Cross-sectional patient-reported outcome measuring of health-related quality of life with establishment of cancer- and treatment-specific functional and symptom scales in patients with penile cancer.
        Clin Genitourin Cancer. 2018; 16: e1215-e1220
        • Kieffer JM
        • Djajadiningrat RS
        • van Muilekom EAM
        • Graafland NM
        • Horenblas S
        • Aaronson NK.
        Quality of life for patients treated for penile cancer.
        J Urol. 2014; 192: 1105-1110
      7. Pardo Munevar C, Mina Riascos S, García-Perdomo HA. Evaluación de la calidad de vida en pacientes con cáncer de pene: Una revisión sistemática. Ciencia e Innovación en Salud. 2020. e99: 410–417.

      8. García-Perdomo HA, Osorio Lasso IC. Mental health as part of the integrative palliative care in all levels of care in urooncology. Aging Ment Health. 2022; 23;1–2. https://doi.org/10.1080/13607863.2022.2068127.

        • Pettaway CA
        • Spiess PE.
        Multimodality treatment of penile cancer: Part 2.
        Urol Oncol. 2022; 40: 207-208
        • Sansalone S
        • Silvani M
        • Leonardi R
        • Vespasiani G
        • Iacovelli V.
        Sexual outcomes after partial penectomy for penile cancer: results from a multi-institutional study.
        Asian J Androl. 2017; 19: 57-61
        • Romero FR
        • Richter Pereira Dos Santos Romero K
        • de Mattos MAE
        • Camargo Garcia CR
        • de Carvalho Fernandes R
        • Cardenuto Perez MD
        Sexual function after partial penectomy for penile cancer.
        Urology. 2005; 66: 1292-1295
        • Gulino G
        • Sasso F
        • Palermo G
        • et al.
        Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma.
        Indian J Uro. 2013; 29 (Apr): 119-123
        • Croghan SM
        • Compton N
        • Daniels AE
        • Fitzgibbon L
        • Daly PJ
        • Cullen IM.
        Phallus preservation in penile cancer surgery: patient-reported aesthetic & functional outcomes.
        Urology. 2021; 152: 60-66
        • Matulewicz RS
        • Flum AS
        • Helenowski I
        • et al.
        Centralization of penile cancer management in the United States: a combined analysis of the American Board of Urology and National Cancer Data Base.
        Urology. 2016; 90: 82-88
        • Johnson T v.
        • Hsiao W
        • Delman KA
        • Jani AB
        • Brawley OW
        • Master VA
        Extensive inguinal lymphadenectomy improves overall 5-year survival in penile cancer patients: Results from the surveillance, epidemiology, and end results program.
        Cancer. 2010; 116: 2960-2966